For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250702:nRSB2910Pa&default-theme=true
RNS Number : 2910P Sabre Insurance Group PLC 02 July 2025
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE MARKET
ABUSE REGULATION (EU NO. 596/2014) AS IT FORMS PART OF UK DOMESTIC LAW BY
VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("MAR").
2 July 2025
Sabre Insurance Group plc
("Sabre" or the "Company")
Transaction in Own Shares
and
Total Voting Rights
The Company announces that in accordance with the authority given by its
shareholders at its Annual General Meeting on 22 May 2025 and pursuant to the
Company's share buy-back announced on 01 July 2025, it has purchased for
cancellation through Panmure Liberum Limited, the following ordinary shares in
the capital of the Company ("Ordinary Shares"):
Date of purchase: 01 July 2025
Aggregate number of ordinary shares purchased: 28,663
Trading venue: London Stock Exchange
Lowest price paid per share (p): 146.6p
Highest price paid per share (p): 147.8p
Average price paid per share (p): 147.0p
Following cancellation of the above Ordinary Shares, the Company will have
249,971,337 Ordinary Shares in issue. No Ordinary Shares are held in treasury.
This number represents the total voting rights in the Company and may be used
by shareholders as the denominator for the calculations by which they can
determine if they are required to notify their interest in, or a change to
their interest in the Company under the Financial Conduct Authority's
Disclosure Guidance and Transparency Rules.
For further information, please contact:
Investor enquiries 01306 747 272
Sabre Insurance Group plc investor.relations@sabre.co.uk (mailto:investor.relations@sabre.co.uk)
Geoff Carter / Adam Westwood
Media enquiries 020 7260 2700
Teneo sabre@teneo.com (mailto:sabre@teneo.com)
James Macey White / Ffion Dash
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSFLFIRDRILIIE